findmyKOL
Clinical trialNCT03433183CompletedPhase 2Interventional

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

SponsorSarcoma Alliance for Research through CollaborationEnrollment21Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S National Medical Center

    Washington D.C., District of Columbia, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • National Cancer Institute

    Bethesda, Maryland, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • Washington University

    St Louis, Missouri, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2019
Primary completion
22 Jun 2022
Completion
1 Oct 2023
Last update posted
27 May 2026
Registered enrollment
21
Registry id
NCT03433183
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.